A Study to Assess The Effects Of Effexor XR On Cardiac Repolarization In Healthy Adult Subjects
Completed · Phase 1 · Has a placebo group
Conditions studied: Healthy Subjects
In brief
The purpose of this study is to demonstrate a lack of effect of venlafaxine (Effexor XR) on QTc intervals relative to time matched placebo in healthy volunteers
Key facts
- Study ID
- NCT02637193
- Run by
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- People needed
- 54
- Starts
- 2015-12-01
- Expected to finish
- 2016-07-01
- Last updated by the study team
- 2021-01-27
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
Where it is running
- Pfizer New Haven Clinical Research Unit — New Haven, Connecticut, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.